De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (DeADT)

BACKGROUND: Men with prostate cancer are often castrated with long-acting injectable drugs termed androgen deprivation therapy (ADT). Although many benefit, ADT is also used in patients with little or nothing to gain. The best ways to stop this practice are unknown, and range from blunt pharmacy res...

Descripción completa

Detalles Bibliográficos
Autores principales: Skolarus, Ted A., Hawley, Sarah T., Wittmann, Daniela A., Forman, Jane, Metreger, Tabitha, Sparks, Jordan B., Zhu, Kevin, Caram, Megan E. V., Hollenbeck, Brent K., Makarov, Danil V., Leppert, John T., Shelton, Jeremy B., Shahinian, Vahakn, Srinivasaraghavan, Sriram, Sales, Anne E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262964/
https://www.ncbi.nlm.nih.gov/pubmed/30486836
http://dx.doi.org/10.1186/s13012-018-0833-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262964/
https://www.ncbi.nlm.nih.gov/pubmed/30486836
http://dx.doi.org/10.1186/s13012-018-0833-7

Ejemplares similares